stemsavelogo

Select Country

877-783-6728 (877-StemSave)

StemSave Blog

Retinal Disease Blindness Treated with Stem Cells in Phase II Clinical Trial

Posted by hunter@stemsave.com on Mar 11, 2019 2:15:00 PM

A Phase II clinical trial is currently underway to evaluate the efficacy of retinal progenitor cells in treating a retinitis pigmentosa that causes visual impairment and, in severe cases, blindness. In an earlier clinical trial, the stem cells were used to create new photo receptors, with patients reporting improvements in vision. In follow-ups conducted between 18 days and 2 months following treatment, patients were able to read three additional lines in a standard eye test chart.

Read More

Topics: retinal blindness, stem cell treatment

Retinitis Pigmentosa Stem Cell Protocol Goes into Clinical Trials

Posted by anna@stemsave.com on Nov 5, 2015 2:03:00 PM

Dr. Henry Klassen of UC Irvine has initiated an FDA approved stem cell based clinical trial for the treatment of Retinitis Pigmentosa (RP) through the regeneration of damaged retinal tissue. RP is caused by the slow decay of photoreceptors in the retina, which provide vital chemical communication to the brain. The disease is thought to derive from mutations in genes responsible for rods and cones, which ultimately lead to blindness. There is no current treatment for RP.

Read More

Topics: stemsaveblog, Retinitis Pigmentosa, Eyes, clinical trial, retinal blindness, mesenchymal stem cells

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

    Recent Posts

    Posts by Topic

    see all